Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors.
- 1 May 1989
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 86 (9) , 3011-3015
- https://doi.org/10.1073/pnas.86.9.3011
Abstract
Homologous (agonist-specific) desensitization of .beta.-adrenergic receptors (.beta.ARs) is accompanied by and appears to require phosphorylation of the receptors. We have recently described a novel protein kinase, .beta.AR kinase, which phosphorylates .beta.ARs in vitro in an agonist-dependent manner. This kinase is inhibited by two classes of compounds, polyanions and synthetic peptides derived from the .beta.2-adrenergic receptor (.beta.2AR). In this report we describe the effects of these inhibitors on the process of homologous desensitization induced by the .beta.-adrenergic agonist isoproterenol. Permeabilization of human epidermoid carcinoma A431 cells with digitonin was used to permit access of the charged inhibitors to the cytosol; this procedure did not interfere with the pattern of isoproterenol-induced homologous desensitization of .beta.2AR-stimulated adenylyl cyclase. Inhibitors of .beta.AR kinase markedly inhibited homologous desensitization of .beta.2ARs in the permeabilized cells. Inhibition of desensitization by heparin, the most potent of the polyanion inhibitors of .beta.AR kinase, occurred over the same concentration range (5-50 nM) as inhibition of purified .beta.AR kinase assessed in a reconstituted system. Inhibition of desensitization by heparin was accompanied by a marked reduction of receptor phosphorylation in the permeabilized cells. Whereas inhibitors of .beta.AR kinase inhibited homologous desensitization, inhibitors of protein kinase C and of cyclic-nucleotide-dependent protein kinases were ineffective. These data establish that phosphorylation of .beta.ARs by .beta.AR kinase is an essential step in homologous desensitization of the receptors. They further suggest a potential therapeutic value of inhibitors of .beta.AR kinase in inhibiting agonist-induced desensitization.This publication has 28 references indexed in Scilit:
- Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitizationNature, 1988
- A novel catecholamine-activated adenosine cyclic 3',5'-phosphate independent pathway for .beta.-adrenergic receptor phosphorylation in wild-type and mutant S49 lymphoma cells: mechanism of homologous desensitization of adenylate cyclaseBiochemistry, 1986
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Mammalian .beta.2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase systemBiochemistry, 1984
- A method for incorporating macromolecules into adherent cells.The Journal of cell biology, 1984
- On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin.The Journal of cell biology, 1981
- Modulation of adenylate cyclase activity by sulfated glycosaminoglycans II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissuesBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Effects of polyamines and polyanions on a cyclic nucleotide-independent and a cyclic AMP-dependentBiochimica et Biophysica Acta (BBA) - General Subjects, 1977
- A highly sensitive adenylate cyclase assayAnalytical Biochemistry, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970